Astaxanthin and xanthophylls composition and application thereof

Abstract

The invention aims at providing an astaxanthin and xanthophylls composition. The effective ingredients of the staxanthin and xanthophylls composition are astaxanthin and xanthophylls. The ratio of the astaxanthin to the xanthophylls is 1:4-8. The astaxanthin and xanthophylls composition is used for preparing medicines for treating eye diseases and has the good effects on inhibiting choroid neovascularization and inhibiting VEGF (vascular endothelial growth factors) generation.

Description

technical field [0001] The invention relates to a composition containing astaxanthin and lutein, and also relates to its application, which belongs to the field of medicine. Background technique [0002] Choroidal neovascularization refers to proliferating blood vessels from the choroidal capillaries that extend through breaks in Bruch's membrane, between Bruch's membrane and the retinal pigment epithelium, or between the neural retina and the retinal pigment epithelium, or between the retinal pigment epithelium and the choroid Proliferation and formation, many diseases involving the RPE-Bruch membrane-choriocapillary complex can lead to the formation of CNV, also known as subretinal neovascularization, which should be detected early and treated in time. [0003] Vascular endothelial growth factor (English: vascular endothelial growth factor, abbreviation: VEGF) is a specific heparin-binding growth factor for vascular endothelial cells, which can induce angiogenesis in vivo,...

AI Technical Summary

Problems solved by technology

Although the above-mentioned various compositions have a health-care effect on the eyes according to the content of the invention, what components play an important contribution in each component, and the effects of which are specifically implemented in terms of the inhibition of which factors, etc. not found in the relevant literature

Images